PTIX · Protagenic Therapeutics

Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. The company was founded in 2004 and is based in New York, New York.

149 Fifth Avenue, New York, NY, 10010, United States
Biotechnology
Healthcare

Market Cap

829.1K

52 Wk Range

$0.13 - $2.38

Previous Close

$0.46

Open

$0.45

Volume

3,095

Day Range

$0.42 - $0.45

Enterprise Value

2.612M

Cash

2.213M

Avg Qtr Burn

-509.7K

Insider Ownership

6.20%

Institutional Own.

3.69%

Qtr Updated

Dec 31st 2025